GREGoRi Innovation Projects (U01 Clinical Trial Optional)
The summary for the GREGoRi Innovation Projects (U01 Clinical Trial Optional) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
GREGoRi Innovation Projects (U01 Clinical Trial Optional): The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. This Notice of Funding Opportunity is intended to stimulate the development and testing of highly innovative experimental or computational approaches for rare disease diagnosis, that have the potential to make transformative improvements to the current state of the art.
| Federal Grant Title: | GREGoRi Innovation Projects (U01 Clinical Trial Optional) |
| Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-HG-27-013 |
| Type of Funding: | Cooperative Agreement |
| CFDA Numbers: | 93.172 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | October 30th, 2026 |
| Original Application Deadline: | October 30th, 2026 |
| Posted Date: | June 18th, 2026 |
| Creation Date: | June 18th, 2026 |
| Archive Date: | December 9th, 2026 |
| Total Program Funding: | $7,500,000 |
| Maximum Federal Grant Award: | $500,000 |
| Minimum Federal Grant Award: | $3 |
| Expected Number of Awards: | 10 |
| Cost Sharing or Matching: | No |
| Last Updated: | June 18th, 2026 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Grant Announcement Contact
- GREGoRi Program Team
[email protected]
[email protected] - Similar Government Grants
- • Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials N...
- • Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, C...
- • Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants ...
- • IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)
- • GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
- • Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44)
- • Near-Term Technology Development for Genome Sequencing - STTR (R41/R42)
- • Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
- More Grants from the National Institutes of Health
- • Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not ...
- • NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
- • Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
- • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
- • The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Researc...